Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promethazine vs Haloperidol combination for prevention of postoperative nausea and vomiting after bariatric surgery
IRCT20170805035510N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative nausea and vomiting (PONV) comparing Promethazine + Dexamethasone + Ondansetron with Haloperidol + Dexamethasone + Ondansetron (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting. Started Mar 2018; status: completed.
02
Drugs
promethazinehaloperidoldexamethasoneondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20170805035510N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170805035510N3.